RNAC
Cartesian Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.39
-0.73 ▼ -8.99%
🌙 3월 13일 6:45 PM ET (한국 3/14 07:45)
$7.37
-0.02 ▼ -0.27%
| Index | RUT | P/E | - | EPS (ttm) | -5.02 | Insider Own | 62.14% | Shs Outstand | 0.03B | Perf Week | 7.88% |
| Market Cap | 0.20B | Forward P/E | - | EPS next Y | -8.68% | Insider Trans | -0.05% | Shs Float | 0.01B | Perf Month | 15.47% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | -0.87 | Inst Own | 19.54% | Short Float | 21.4% | Perf Quarter | -5.86% |
| Income | -0.13B | P/S | 69.96 | EPS this Y | 34.46% | Inst Trans | -10.01% | Short Ratio | 10.72 | Perf Half Y | -25.8% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 12.18% | ROA | - | Short Interest | 2.15M | Perf YTD | 2.5% |
| Book/sh | -4.85 | P/C | 1.57 | EPS past 3/5Y | - 24.48% | ROE | - | 52W High | -57.58% ($17.42) | Perf Year | -55.51% |
| Cash/sh | 4.72 | P/FCF | - | Sales past 3/5Y | -70.66% -29.96% | ROIC | - | 52W Low | 23.58% ($5.98) | Perf 3Y | -82.89% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 90.47% | Gross Margin | -5.79% | Volatility(W/M) | 16.71% 11.19% | Perf 5Y | -94.23% |
| Dividend TTM | - | EV/Sales | 29.8 | Sales Y/Y TTM | - | Oper. Margin | -3099.93% | ATR (14) | 0.79 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.65 | EPS Q/Q | -216% | Profit Margin | -4658.63% | RSI (14) | 48.89 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.65 | Sales Q/Q | 144.7% | SMA20 | -1.47% ($7.5) | Beta | 0.35 | Target Price | $36.5 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | 1.33% ($7.29) | Rel Volume | 0.75 | Prev Close | $8.12 |
| Employees | 75 | LT Debt/Eq | - | EPS/Sales Surpr. | -306.53% 530.07% | SMA200 | -19.18% ($9.14) | Avg Volume(3M) | 0.20M | Price | $7.39 |
| IPO | 2016/6/22 | Option/Short | Yes/Yes | Trades | 2020 | Volume | 150,715 | Change | -8.99% |
뉴스 로딩 중...